Research Report on China Pharmaceutical Market

Most up-to-date research on "The Pharmaceutical Market: China" to its huge collection of research reports.


We remain bullish on China's pharmaceutical sector despite the slowdown in the economy and political reshuffle. We do not think the reshuffle will have any adverse changes or cause any reversals to healthcare reform given that the country has been rolling out various healthcare schemes in 2012 and that a key person overseeing these healthcare reform plans is Vice Premier Li Keqiang, the man who may potentially take over from Premier Wen Jiabao in the reshuffle. However, the business environment will potentially be threaten by cost- containment policies as the country will have to contain its ever-growing healthcare expenditure.

Headline Expenditure Projections

  • Pharmaceuticals: CNY432bn (US66.7bn) in 2011to CNY521bn (US$82.2bn) in 2012; +20.6% in local currency and +23.0% in US dollar terms. Forecast broadly in line with Q412.
  • Healthcare: CNY2313bn (US$358bn) in 2011 to CNY2,602bn (US$410bn) in 2012; +12.5% in local currency terms and +14.7% in US dollar terms. Forecast broadly in line with Q412.
  • Medical Devices: CNY117bn (US$18.2bn) in 2011 to CNY146bn (US$22.8bn) in 2012; +24.3% in local currency terms and +26.7% in US dollar terms. Forecast broadly in line with Q412.

Risk/Reward Rating

China continues to rank fourth out of the 18 key markets in BMI's Q113 Asia Pacific Pharmaceutical Risk/Reward Ratings with an unchanged score of 62.5 Its high ranking on the table (just behind developed markets Japan, South Korea and Australia) is largely due to the strong growth potential of the pharmaceutical market that is underpinned by a large and increasingly affluent population and an increasing burden of non-communication diseases.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Related Report
OVERVIEW OF THE PHARMACEUTICAL MARKET IN BOTSWANA Growing appreciation of the value of a healthy population, combined with improvements in its economy, will boost investments in medical services. The healthcare system is largely government-funded, and therefore people on low incomes are able to seek medical treatment. However, communication and transport hindrances as well as...

THE PHARMACEUTICAL MARKET: ESTONIA - REVIEW Our outlook for the Estonian pharmaceutical market remains unchanged. While epidemiological trends will continue to stimulate the volume development of the market, patent expirations and government encouragement of the consumption of cheaper generic medicine will hamper value growth. The market will remain reliant on imports, which...

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact: